Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
Hiroki Sato(Tokyo Medical University), Shinichi Toyooka(Okayama University Hospital)
Cited by 27
Related Papers
Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in <i>EGFR</i> -Mutant Lung Cancer
|Clinical Cancer Research|2020|381